Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Orion Group Holdings Inc ORN

Orion Group Holdings, Inc. is a specialty construction company that serves the infrastructure, industrial, and building sectors. The Company provides services both on and off the water in the continental United States, Alaska, Hawaii, Canada and the Caribbean Basin. It operates through two segments: marine and concrete. The marine segment provides construction and dredging services relating to... see more

NYSE:ORN - Post Discussion

Orion Group Holdings Inc > ORYZON Receives "Intention to Grant" Communication for Paten
View:
Post by whytestocks on Sep 11, 2024 5:45pm

ORYZON Receives "Intention to Grant" Communication for Paten

News; $ORN ORYZON Receives "Intention to Grant" Communication for Patent Relating to the Use of Vafidemstat in Borderline Personality DisorderMADRID and CAMBRIDGE, Mass., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the European Patent Office ...ORN - ORYZON Receives "Intention to Grant" Communication for Patent Relating to the Use of Vafidemstat in Borderline Personality Disorder
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities